{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"submitter":["Odenkirk MT"],"funding":["U.S. Department of Energy","U.S. Environmental Protection Agency","U.S. Department of Health and Human Services","NIEHS NIH HHS","Department of Health, Australian Government","Australian Government","NIGMS NIH HHS"],"pubmed_abstract":["Alzheimer's disease (AD) is a neurodegenerative disease with a complex etiology influenced by confounding factors such as genetic polymorphisms, age, sex, and race. Traditionally, AD research has not prioritized these influences, resulting in dramatically skewed cohorts such as three times the number of Apolipoprotein E (APOE) ε4-allele carriers in AD relative to healthy cohorts. Thus, the resulting molecular changes in AD have previously been complicated by the influence of apolipoprotein E disparities. To explore how apolipoprotein E polymorphism influences AD progression, 62 post-mortem patients consisting of 33 AD and 29 controls (Ctrl) were studied to balance the number of ε4-allele carriers and facilitate a molecular comparison of the apolipoprotein E genotype. Lipid and protein pert"],"journal":["Journal of proteome research"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11255128"],"repository":["biostudies-literature"],"pubmed_title":["Deciphering ApoE Genotype-Driven Proteomic and Lipidomic Alterations in Alzheimer's Disease Across Distinct Brain Regions."],"pmcid":["PMC11255128"],"funding_grant_id":["RD 84003201","P42 ES027704","APP1138673","RM1 GM145416","APP1164692","P42 ES031009","DE-AC05-76RL01830","20100104","R01 GM141277"],"pubmed_authors":["Stratton KG","Zheng X","Monroe ME","Roberts BR","Bloodsworth KJ","Smith RD","Masters CL","Mclean CA","Nicora CD","Doecke JD","Odenkirk MT","Baker ES","Burnum-Johnson KE","Kyle JE"],"additional_accession":[]},"is_claimable":false,"name":"Deciphering ApoE Genotype-Driven Proteomic and Lipidomic Alterations in Alzheimer's Disease Across Distinct Brain Regions.","description":"Alzheimer's disease (AD) is a neurodegenerative disease with a complex etiology influenced by confounding factors such as genetic polymorphisms, age, sex, and race. Traditionally, AD research has not prioritized these influences, resulting in dramatically skewed cohorts such as three times the number of Apolipoprotein E (APOE) ε4-allele carriers in AD relative to healthy cohorts. Thus, the resulting molecular changes in AD have previously been complicated by the influence of apolipoprotein E disparities. To explore how apolipoprotein E polymorphism influences AD progression, 62 post-mortem patients consisting of 33 AD and 29 controls (Ctrl) were studied to balance the number of ε4-allele carriers and facilitate a molecular comparison of the apolipoprotein E genotype. Lipid and protein pert","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jan","modification":"2025-04-19T20:47:48.793Z","creation":"2025-04-19T20:47:48.793Z"},"accession":"S-EPMC11255128","cross_references":{"pubmed":["38236019"],"doi":["10.1021/acs.jproteome.3c00604"]}}